| Financial Year |
March 31 2023 |
| Monetary Funds |
174,892,060.97 |
| Held-for-trading Financial Assets |
85,849,889.10 |
| Notes Receivable |
276,475.70 |
| Accounts Receivable |
13,850,245.81 |
| Advances to Suppliers |
34,572,374.64 |
| Other Receivables |
1,405,418.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
34,077,305.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,158,211.71 |
| Total Current Assets |
348,081,981.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
49,586,256.11 |
| Under-construction Projects |
135,956,912.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,068,085.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,266,882.27 |
| Deferred Income Tax Assets |
3,501,731.98 |
| Other Non-Current Assets |
35,678,098.00 |
| Sub-Total of Non-Current Assets |
263,862,507.27 |
| Total Assets |
611,944,488.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,180,034.00 |
| Accounts Payable |
7,690,767.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,832,624.09 |
| Taxes Payable |
5,600,372.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,411,215.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,033,973.62 |
| Other Current Liabilities |
1,673,928.32 |
| Sub-Total of Current Liabilities |
61,305,626.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
287,063.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
956,907.97 |
| Total Liabilities |
62,262,534.33 |
| Paid-In Capital(Or Share Stock) |
235,200,000.00 |
| Capital Surplus |
207,554,555.35 |
| Surplus Reserve |
53,888,897.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
60,537,238.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
549,681,954.60 |
| Owner's Equity（Stockholder's Equity） |
549,681,954.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
611,944,488.93 |
